Whatever your stage of clinical development, you need a trusted partner providing global regulatory capabilities to support your product. Canny’s consultants understand the importance of delivering sound regulatory strategies and operational support for your products, and provide you with feasible approaches and act as liaison with various regulatory agencies, both on technical and regulatory issues.
By continuously monitoring the global regulatory landscape, and years of submission experiences with NMPA, FDA, EMA, we can advise you across all spectrum of activities and technical functions to stay ahead of any regulatory risks and keep your research on time and budget.
-
2400+
Drug registration projects
-
640+
Global drug registration customers
Full Regulatory & Submission Services
Regulatory services for innovative drugs & generics globally, including chemical drugs and biologics products, IND/CTA/NDA, supported with eCTD submission.
Expertise with Global Reach
50+ experts with years of working experience with FDA, NMPA, and EU health authorities, and a deep understanding of ongoing regulatory reforms worldwide.
Feasible Regulatory Strategy
We can provide you with feasible submission strategies and proactive planning which applying up-to-date, robust regulatory intelligence.
Demonstrated Track Record
We have successfully supported thousands of regulatory approvals globally, including MRCT approvals of COVID-19 vaccines in Africa, Europe and APAC.
CDE Communication Meeting Application
Submission Dossier Preparing
Gap Analysis
DMF/CEP Registration
Consulting Services
QC Testing Arrangement
Renew & Variation Application
Regulatory Strategy Development